The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
about
Efflux-mediated drug resistance in bacteria: an updatePseudomonas Exotoxin A: optimized by evolution for effective killingOrigin and Impact of Nitric Oxide in Pseudomonas aeruginosa BiofilmsPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsRole of apoptosis in diseaseToll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosisMolecular Basis for the Recognition of Structurally Distinct Autoinducer Mimics by the Pseudomonas aeruginosa LasR Quorum-Sensing Signaling ReceptorStructure of the Type III Secretion Effector Protein ExoU in Complex with Its Chaperone SpcUStructural, functional, and inhibition studies of a Gcn5-related N-acetyltransferase (GNAT) superfamily protein PA4794: a new C-terminal lysine protein acetyltransferase from pseudomonas aeruginosaStructural Basis for Substrate Specificity in ArnB. A Key Enzyme in the Polymyxin Resistance Pathway of Gram-Negative BacteriaTrapped intermediates in crystals of the FMN-dependent oxidase PhzG provide insight into the final steps of phenazine biosynthesisRaloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulenceIdentification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screenActivity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosisA systems biology approach to drug targets in Pseudomonas aeruginosa biofilmPseudomonas aeruginosa directly shunts β-oxidation degradation intermediates into de novo fatty acid biosynthesisGenetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS productionSystematic mutational analysis of the putative hydrolase PqsE: toward a deeper molecular understanding of virulence acquisition in Pseudomonas aeruginosanfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosaExternally controlled triggered-release of drug from PLGA micro and nanoparticlesBiochemical Characterization of the Split Class II Ribonucleotide Reductase from Pseudomonas aeruginosaElucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa(1)H, (13)C and (15)N resonance assignments and secondary structure analysis of translation initiation factor 1 from Pseudomonas aeruginosaThe effect of specific rhlA-las-box mutations on DNA binding and gene activation by Pseudomonas aeruginosa quorum-sensing transcriptional regulators RhlR and LasR.The Pseudomonas aeruginosa Vfr regulator controls global virulence factor expression through cyclic AMP-dependent and -independent mechanismsSound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro.Synthesis, characterization and antimicrobial activity of water-soluble silver(i) complexes of metronidazole drug and selected counter-ions.The bioactivity of plant extracts against representative bacterial pathogens of the lower respiratory tract.The Pseudomonas aeruginosa Chp chemosensory system regulates intracellular cAMP levels by modulating adenylate cyclase activity.Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development.Lauroyl Arginate Ethyl Blocks the Iron Signals Necessary for Pseudomonas aeruginosa Biofilm Development.SuhB Regulates the Motile-Sessile Switch in Pseudomonas aeruginosa through the Gac/Rsm Pathway and c-di-GMP SignalingMULTILOCUS SEQUENCE TYPING OF CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA ISOLATES FROM PATIENTS PRESENTING AT PORT ELIZABETH HOSPITALS, SOUTH AFRICA.Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser.The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosaIn vitro and in vivo characterization of the Pseudomonas aeruginosa cyclic AMP (cAMP) phosphodiesterase CpdA, required for cAMP homeostasis and virulence factor regulation.Blocking phosphatidylcholine utilization in Pseudomonas aeruginosa, via mutagenesis of fatty acid, glycerol and choline degradation pathways, confirms the importance of this nutrient source in vivoUsing matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours.Initial microbial spectrum in severe secondary peritonitis and relevance for treatment.Caveolin-1 modifies the immunity to Pseudomonas aeruginosa
P2860
Q24609407-EFB45F93-948B-4B24-93E2-A134315999C4Q26781376-B0FCFC8A-E33A-45D1-8029-63BE4981DC54Q26799670-E597BD6E-6315-495E-A89A-0D42B39D41C0Q26823401-5381CE37-5203-4B2C-A1EF-17E8403C1C09Q26865637-A79BA854-93DF-44F2-8BBB-CA45E62222E1Q27010697-7365AE9F-6C2C-48FC-9236-242ED72C2551Q27657552-333326FF-9A2A-4D52-833A-57EE0740FE27Q27675175-4A7C0A43-7590-4458-9F43-C39078069EFEQ27679867-23C62BC4-3C22-4A9B-B153-F25CC316A24BQ27681447-41E7E42B-4286-4BA1-A720-E11491D61E72Q27685293-FA5293BF-E5FF-466B-9AB3-08592A3BACE9Q28271536-73B530AC-B38E-4125-897C-1988FACEDA39Q28472300-6E382C98-3727-4F24-9591-A51961DAFA52Q28475562-879D3698-1941-4169-B185-2C889290F043Q28482361-DA38FF58-EAE4-49BA-8647-B2938E67744AQ28492854-F3F837CD-C484-4A03-AB50-4114A209D4A8Q28493036-87786539-9817-4B6E-BB7D-750C70D4926FQ28533223-89699B2E-ABBB-4D93-9C4A-8118E4993A77Q28533745-D096B82F-3755-4786-85F9-35050B9A5FC2Q28542537-8A18D049-B082-4408-BAB1-899E0F9CDF26Q28546909-1DC7E539-5B29-4411-86DA-033CC91920CEQ28551971-4804AA32-3508-406D-8CCE-4529A59508AAQ28829977-8E6C7762-0575-4CD9-B1E1-7EC4754DD96AQ29346780-6B14D824-50CA-42CF-9E0F-97B9B77B60ADQ29346792-BD9BEAE7-1ED7-45C7-8DDA-6B333FCFD497Q30404353-EDC7C4D6-CE05-4344-994C-5E38288081E8Q30924728-36C60004-AFF9-40AA-9924-ABABC1D20315Q33457725-207205CF-20F6-4E6C-854F-8FE59DF2E34BQ33546596-968F6875-B06A-4229-86A9-A92F07B98AA4Q33563346-DB46DADA-2E00-4D0B-BF9C-1F3DA77FB1FAQ33736464-210E42A5-73F1-4845-A6CC-90C5931C28F2Q33774868-231FCAAE-E290-475F-ABBB-024E1E80DFDDQ33813460-02AD5FF4-DAE8-4BF9-ABA7-A5F2997FD858Q33832119-EA281AFB-CF21-4369-A56D-A929B576B1E0Q33856134-88D2E349-6FD3-4D69-B2DC-E7E679B9F412Q33876925-44D1CBAD-5EDC-412B-A315-4D4C8C7D5D9DQ33961741-4D5BA84B-A073-46B8-A0AC-A90CE7CD3348Q33973352-554A58A6-C05C-47B8-86FC-F908905E3C9EQ33975052-561BF437-1362-41D4-AA3A-7DBC4B700189Q33979216-26F48165-29BB-4D32-BE27-1EE91DBA4765
P2860
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
@en
type
label
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
@en
prefLabel
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
@en
P1433
P1476
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
@en
P2093
James A Driscoll
Steven L Brody
P304
P356
10.2165/00003495-200767030-00003
P577
2007-01-01T00:00:00Z
P6179
1000478513